Impact of Pharmacist-led Home Medication Review on Economic, Clinical, and Humanistic Outcomes in Elderly Type-2 Diabetic Patients
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Change in glycemic control as measured by HbA1c levels.
研究概览
简要总结
This is a randomised parallel-group controlled trial designed to evaluate the impact of pharmacist-led Home Medication Review on clinical economic and humanistic outcomes in elderly patients with Type 2 Diabetes Mellitus. A total of 200 patients aged 60 years and above will be recruited. Participants will be randomly allocated in a 1 to1 ratio to either an intervention group receiving pharmacist-led HMR in addition to standard care or a control group receiving standard care only. The HMR intervention consists of structured home visits by a pharmacist to review medications, provide patient education, and collaborate with physicians to resolve drug-related problems.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 60.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Patients aged 60 years or above.
- •Diagnosed with Type 2 Diabetes Mellitus.
- •Currently undergoing standard pharmacotherapy for diabetes management.
- •Willing to provide informed consent and participate in the study.
排除标准
- •Patients with terminal illnesses.
- •Patients with severe complications of diabetes, such as end-stage renal disease, may be excluded from participation.
- •Patients with psychiatric illnesses or cognitive impairments.
- •Patients with a history of stroke that significantly limits their ability to engage in the intervention or adhere to the study protocol.
- •Uncontrolled comorbidities require immediate intensive care.
结局指标
主要结局
Change in glycemic control as measured by HbA1c levels.
时间窗: Baseline, 6 months, and 12 months.
次要结局
- Change in medication adherence, and Change in quality of life.(Baseline, 6 months, and 12 months.)
- Change in direct medical costs, including hospital visits and medication expenses and Number and category of Drug-Related Problems (DRPs) identified and addressed.(Baseline, 6 months, and 12 months.)
研究者
Mr Radhakishan M
NGSM Institute of Pharmaceutical Sciences